These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34080086)

  • 1. Preparation and Characterization of a Lutein Solid Dispersion to Improve Its Solubility and Stability.
    Lim C; Kang JK; Jung CE; Sim T; Her J; Kang K; Lee ES; Youn YS; Choi HG; Oh KT
    AAPS PharmSciTech; 2021 Jun; 22(5):169. PubMed ID: 34080086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of Films to Anticipate Effect of Drug Load and Polymer on Dissolution Performance from Tablets of Amorphous Itraconazole Spray-Dried Dispersions.
    Honick M; Sarpal K; Alayoubi A; Zidan A; Hoag SW; Hollenbeck RG; Munson EJ; Polli JE
    AAPS PharmSciTech; 2019 Nov; 20(8):331. PubMed ID: 31677012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
    Mahmah O; Tabbakh R; Kelly A; Paradkar A
    J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and pharmacokinetic study of itraconazole solid dispersions prepared by solvent-controlled precipitation and spray-dry methods.
    Sim T; Lim C; Lee JW; Kim DW; Kim Y; Kim M; Choi S; Choi HG; Lee ES; Kim KS; Kang W; Oh KT
    J Pharm Pharmacol; 2017 Dec; 69(12):1707-1715. PubMed ID: 28872678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Polymers on the Physical and Chemical Stability of Spray-dried Amorphous Solid Dispersion: Dipyridamole Degradation Induced by Enteric Polymers.
    Peng T; She Y; Zhu C; Shi Y; Huang Y; Niu B; Bai X; Pan X; Wu C
    AAPS PharmSciTech; 2018 Aug; 19(6):2620-2628. PubMed ID: 29916195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiscale Computational Modeling of the Nanostructure of Solid Dispersions of Hydroxypropyl Methylcellulose Acetate Succinate (HPMCAS) and Phenytoin.
    Huang W; Mandal T; Larson RG
    Mol Pharm; 2017 Oct; 14(10):3422-3435. PubMed ID: 28829134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved human bioavailability of vemurafenib, a practically insoluble drug, using an amorphous polymer-stabilized solid dispersion prepared by a solvent-controlled coprecipitation process.
    Shah N; Iyer RM; Mair HJ; Choi DS; Tian H; Diodone R; Fähnrich K; Pabst-Ravot A; Tang K; Scheubel E; Grippo JF; Moreira SA; Go Z; Mouskountakis J; Louie T; Ibrahim PN; Sandhu H; Rubia L; Chokshi H; Singhal D; Malick W
    J Pharm Sci; 2013 Mar; 102(3):967-81. PubMed ID: 23280631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pre-formulation study of a polymeric solid dispersion of paclitaxel prepared using a quasi-emulsion solvent diffusion method to improve the oral bioavailability in rats.
    Piao H; Yang L; Piao H; Wang P; Shi H; Fang L; Cui F
    Drug Dev Ind Pharm; 2016; 42(3):353-63. PubMed ID: 26161937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of HPMCAS/curcumin amorphous solid dispersion in enhancing dissolution and chemical stability of curcumin].
    Liang Q; Wang YR; Deng YY
    Zhongguo Zhong Yao Za Zhi; 2019 Aug; 44(15):3305-3311. PubMed ID: 31602887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Combined Utilization of Plasdone-S630 and HPMCAS-HF in Ziprasidone Hydrochloride Solid Dispersion by Hot-Melt Extrusion to Enhance the Oral Bioavailability and No Food Effect.
    Xue X; Chen G; Xu X; Wang J; Wang J; Ren L
    AAPS PharmSciTech; 2019 Jan; 20(1):37. PubMed ID: 30604142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissolution performance of binary amorphous drug combinations--Impact of a second drug on the maximum achievable supersaturation.
    Trasi NS; Taylor LS
    Int J Pharm; 2015 Dec; 496(2):282-90. PubMed ID: 26456250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An enteric polymer mitigates the effects of gastric pH on oral absorption of poorly soluble weak acid drugs from supersaturable formulations: A case study with dantrolene.
    Kataoka M; Nakanishi R; Umesaki M; Kobayashi M; Minami K; Higashino H; Yamaguchi S; Yamashita S
    Eur J Pharm Biopharm; 2020 Oct; 155():29-36. PubMed ID: 32771692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid antisolvent precipitation: an effective method for ocular targeting of lutein esters.
    Wu M; Feng Z; Deng Y; Zhong C; Liu Y; Liu J; Zhao X; Fu Y
    Int J Nanomedicine; 2019; 14():2667-2681. PubMed ID: 31043780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical Stability and Dissolution of Lumefantrine Amorphous Solid Dispersions Produced by Spray Anti-Solvent Precipitation.
    Bhujbal SV; Pathak V; Zemlyanov DY; Taylor LS; Zhou QT
    J Pharm Sci; 2021 Jun; 110(6):2423-2431. PubMed ID: 33387599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug.
    Mitra A; Li L; Marsac P; Marks B; Liu Z; Brown C
    Int J Pharm; 2016 May; 505(1-2):107-14. PubMed ID: 27012984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypromellose acetate succinate based amorphous solid dispersions via hot melt extrusion: Effect of drug physicochemical properties.
    Sarabu S; Kallakunta VR; Bandari S; Batra A; Bi V; Durig T; Zhang F; Repka MA
    Carbohydr Polym; 2020 Apr; 233():115828. PubMed ID: 32059882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tadalafil solid dispersion formulations based on PVP/VA S-630: Improving oral bioavailability in rats.
    Choi JS; Lee SE; Jang WS; Byeon JC; Park JS
    Eur J Pharm Sci; 2017 Aug; 106():152-158. PubMed ID: 28579005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of hydroxypropyl methylcellulose acetate succinate in an enteric polymer matrix to design controlled-release tablets of amoxicillin trihydrate.
    Hilton AK; Deasy PB
    J Pharm Sci; 1993 Jul; 82(7):737-43. PubMed ID: 8360849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of amorphous solid dispersion formulations of a poorly water-soluble drug, MK-0364.
    Sotthivirat S; McKelvey C; Moser J; Rege B; Xu W; Zhang D
    Int J Pharm; 2013 Aug; 452(1-2):73-81. PubMed ID: 23651642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions.
    Tanno F; Nishiyama Y; Kokubo H; Obara S
    Drug Dev Ind Pharm; 2004 Jan; 30(1):9-17. PubMed ID: 15000425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.